Collection: Pediatric HGH Therapy

In order to determine if HGH is a viable option, we will look at the patient’s bone density levels to determine if the growth plates have been closed or not. This can be done with a simple x-ray. Measure amounts of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in the blood.

Typically, treatment of growth hormone deficiency involves receiving regular injections of synthetic human growth hormone, and children receive daily injections. Treatment usually lasts several years, although results are often seen as soon as three to four months after the injections are started.

The earlier treatment for growth hormone deficiency is started, the better chance the child will have of attaining her normal or near-normal adult height. However, not all children respond well to growth hormone treatment.

Children who have mutations that make their cells unresponsive to the growth hormone may be treated with injections of synthetic human IGF-1 instead.

These injections are reserved for patients who are extremely short and have very low IGF-1 levels, but who passed their growth hormone stimulation testing.

The American Academy of Pediatrics (AAP) recommends that therapy with growth hormone is medically and ethically acceptable for children.

whose extreme short stature prohibits their participation in everyday activities and who have a condition that will benefit from growth hormone therapy. Contact us today! Meet our experts at New Regeneration.